EDGAR Filing Documents for 9999999995-17-002161

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-17-002161

Accepted

2017-08-21 00:15:12

Documents

Effectiveness Date

2017-08-18

Registration Form

S-3

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	595
	Complete submission text file	9999999995-17-002161.txt		1700

Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022

Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311

STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)